ENUMERATION AND CHARACTERISATION OF CIRCULATING TUMOR CELLS (CTC) IN PATIENTS WITH SOLID MALIGNANCIES

Completed

• Conditions: Cancer; 10027476

• Registration Number: NL-OMON30560
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 900

Inclusion Criteria

- Patients suffering from one of the below mentioned solid malignancies. For patients with metastatic disease, only those who will be treated with first line systemic treatment will be recruited.
o metastatic breast cancer (number 100-150)
o localized breast cancer (number 100-150)
o metastatic colorectal cancer (number 100-150)
o localized colorectal cancer (number 100-150)
o metastatic prostate cancer (number 100-150)
o metastatic other tumor types such as testicular cancer, soft tissue sarcoma, renal cell carcinoma, lung carcinoma (in total maximum number 100-150);- Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be assessed with the patient before registration in the trial.;- Before patient randomization, written informed consent must be given and documented to ICH/EU GCP, and national/local regulatory requirements and the local rules followed in the institution

Exclusion Criteria

Geen

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To enumarate and characterize CTC's.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>